The future of colorectal cancer: implications of screening

Wide Field Endoscopic Resection for Advanced Colonic Mucosal Neoplasia: Current Status and Future Directions

(2012) Bronte A. Holt et al.   Clinical Gastroenterology and Hepatology

A microRNA panel to discriminate carcinomas from high-grade intraepithelial neoplasms in colonoscopy biopsy tissue

(2012) Shuyang Wang et al.   GUT

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis

(2012) Trude H Ågesen et al.   GUT

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

(2012) A. D. Roth et al.   JNCI-Journal of the National Cancer Institute

Molecular Predictors of Response to Chemotherapy in Colorectal Cancer

(2011) Rodrigo Dienstmann et al.   CANCER JOURNAL

DNA Methylation of Phosphatase and Actin Regulator 3 Detects Colorectal Cancer in Stool and Complements FIT

(2011) L. J. W. Bosch et al.   Cancer Prevention Research

Microvesicles: Messengers and mediators of tumor progression

(2011) Khalid Al-Nedawi et al.   CELL CYCLE

Organized Colorectal Cancer Screening in Integrated Health Care Systems

(2011) T. R. Levin et al.   EPIDEMIOLOGIC REVIEWS

Cost-effectiveness Analysis of a Quantitative Immunochemical Test for Colorectal Cancer Screening

(2011) Janneke A. Wilschut et al.   GASTROENTEROLOGY

Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large Adenomas

(2011) David A. Ahlquist et al.   GASTROENTEROLOGY

Su1522 Incidence of Lymph Node Metastasis From Sessile or Nonpolypoid Early Colon Cancer: Stratified Criteria to Decide When to Operate or When to Watch

(2011) Tonya Kaltenbach et al.   GASTROINTESTINAL ENDOSCOPY

Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site

(2011) R J C Steele et al.   GUT

miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer

(2011) Yanlei Ma et al.   GUT

Molecular Detection of Tumor Cells in Regional Lymph Nodes Is Associated With Disease Recurrence and Poor Survival in Node-Negative Colorectal Cancer: A Systematic Review and Meta-Analysis

(2011) Nuh N. Rahbari et al.   JOURNAL OF CLINICAL ONCOLOGY

Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients

(2011) R. P. M. Brosens et al.   CELLULAR ONCOLOGY

Lesion isolation by circumferential submucosal incision prior to endoscopic mucosal resection (CSI-EMR) substantially improves en bloc resection rates for 40-mm colonic lesions

(2010) A. Moss et al.   ENDOSCOPY

Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08

(2010) Carmen J. Allegra et al.   JOURNAL OF CLINICAL ONCOLOGY

Preliminary evaluation of a nanotechnology-based approach for the more effective diagnosis of colon cancers

(2010) Niyom Lue et al.   Nanomedicine

Functional delivery of viral miRNAs via exosomes

(2010) D. M. Pegtel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test

(2009) F. A. OORT et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effect of Rising Chemotherapy Costs on the Cost Savings of Colorectal Cancer Screening

(2009) Iris Lansdorp-Vogelaar et al.   JNCI-Journal of the National Cancer Institute

Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer

(2008) T. Schepeler et al.   CANCER RESEARCH

Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging

(2008) Melissa J. Suter et al.   GASTROINTESTINAL ENDOSCOPY

Circulating mutant DNA to assess tumor dynamics

(2008) Frank Diehl et al.   NATURE MEDICINE